Western nutrition and the insulin resistance syndrome: A link to breast cancer

European Journal of Clinical Nutrition

Volumn 53, Issue 2, 1999, Pages 83-87

  Stoll, B A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; Breast cancer; Insulin resistance; Insulin like growth factor; Nutrition; Obesity; Physical exercise; Unsaturated fatty acids; Western diet

Indexed keywords

FATTY ACID; POLYUNSATURATED FATTY ACID; SOMATOMEDIN C;

ATHEROSCLEROSIS; BREAST CANCER; CANCER PREVENTION; CANCER RISK; DISEASE ASSOCIATION; DYSLIPIDEMIA; EXERCISE; FAMILY HISTORY; FAT INTAKE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; LIPID STORAGE; NUTRITION; REVIEW; VISCERA;

EID: 0032998168     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600700     Document Type: Review

References (52)

1. Agostoni C, Riva E, Bellu R, Vincenzo SS & Grazia BM (1994): Relationships between the fatty acid status and insulinemic indexes in obese children. Prostaglandins Leuko. Essent. Fatty Acids 51, 317-321.
2. Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J & Ross RK (1994): Physical exercise and reduced risk of breast cancer in young women. J. Natl. Cancer Inst. 86, 1403-1408.
3. Bao WH, Srinivasan SR & Berenson GS (1996): Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. Circulation 93, 54-59.
4. Barni S, Lissoni P, Brivio F, Fumagalli L, Merlini D & Cataldo M (1994): Serum levels of IGF1 in operable breast cancer in relation to the main prognostic variables. Tumori 80, 212-215.
5. Bjorntorp P, De Jounge K, Sjostrom L & Sullivan L (1970): The effect of physical training on insulin production in obesity. Metabolism 19, 631-638.
6. Boyd NF & McGuire V (1990): Evidence of association between plasma HDL-C and risk factors for breast cancer. J. Natl. Cancer Inst. 82, 460-468.
7. Boyd NF, Connelly P, Lynch H, Kraus M, Michal S, Fili M, Martin LJ, Lockwood G & Tritchler D (1995): Plasma lipids, lipoproteins and familial breast cancer. Cancer Epidemiol. Biomarkers Prev. 4, 117-122.
8. Bruning BF, Bonfrer JMG, Van Noord PAH, Hart AA & De Jong Bakker M (1992): Insulin resistance and breast cancer risk. Int. J. Cancer 52, 511-516.
9. Bruning PF, Van Doorn J, Bonfrer MG, van Noord PAH, Korse CM, Linders TC & Hart AAM (1995): IGFBP3 is decreased in early stage operable premenopausal breast cancer. Int. J. Cancer 62, 266-270.
10. Byrne C, Hankinson SE, Cohen RM, Manson JE, Colditz GA & Speizer FE (1998): Plasma insulin levels and subsequent risk of breast cancer. Am. J. Epidemiol (Suppl.), Abstr. S355.
11. Carroll KK (1991): Dietary fats and cancer. Am. J. Clin. Nutr. 53 (Suppl.), S1064-S1067.
12. Caygill CPJ, Chorlett A & Hill MJ (1996): Fat, fish oil and cancer. Br. J. Cancer 74, 159-164.
13. Clarke RB, Howell A & Anderson E (1997): Type 1 IGF receptor gene expression in normal breast tissue treated with oestrogen and progesterone. Br. J. Cancer 75, 251-257.
14. Coogan PF, Newcomb PA, Clapp RW, Trentham-Dietz A, Baron JA & Longnecker MP (1997): Physical activity in usual occupation and risk of breast cancer. Cancer Causes Control 8, 626-631.
15. Decsi T, Molnan D & Koletzko B (1996): Long chain polyunsaturated fatty acids in plasma lipids of obese children. Lipids 31, 305-311.
16. Del Giudice ME, Fantus IG, Ezzat S, McKeowyn-Eyssen G, Page D & Goodwin PJ (1998): Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res. Treat. 47, 111-120.
17. den Tonkelaar I, Seidell JC, Collette HJA & de Waard F (1994): A prospective study on obesity and subcutaneous fat patterning in relation to breast cancer in postmenopausal women. Br. J. Cancer 69, 352-357.
18. Dreyer L & Olsen JH (1998): Cancer risk of patients discharged with acute myocardial infarct. Epidemiology 9, 178-183.
19. Favoni RE, de Cupis A, Perrotta A, Sforzini S, Amoroso D, Pensa F & Miglietta L (1995): IGF and IGFBP levels in women with early and late stage breast cancer. J. Cancer Res. Clin. Oncol. 121, 674-682.
20. Feskens EJ, Loeber JG & Kromhout D (1994): Diet and physical activity as determinants of hyperinsulinaemia; the Zutphen Elderly Study. Am. J. Epidemiol. 140, 350-360.
21. Frisch RE, Wyshak G & Albright NL (1987): Lower lifetime occurrence of breast cancer and cancer of the reproductive system among former college athletes. Am. J. Clin. Nutr. 45, 328-335.
22. Gamayunova VB, Bobrov YF, Tsyrlina EV, Evtushenko TP & Berstein LM (1997): Comparative study of blood insulin levels in breast and endometrial cancer. Neoplasma 44, 123-126.
23. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE & Pollak M (1998): Circulating concentrations of IGF1 and risk of breast cancer. Lancet 351, 1393-1396.
24. Hellenius MB, Brismar KE, Bergland RH & De Faire UH (1995): Effects on glucose tolerance, insulin secretion, IGF1, IGFBP1 in a randomized controlled diet and exercise study in middle aged men. J. Int. Med. 238, 121-130.
25. Hiatt RA, Friedman GD, Bawol RD & Ury HK (1982): Breast cancer and serum cholesterol. J. Natl. Cancer Inst. 68, 885-889.
26. Igea FJG, Jimenez JAL & Gil SP (1998): Factors associated to an atherogenic lipid profile in premenopausal women without clinical cardiovascular disease. Medicina Clinica 110, 566-569.
27. Kaleko M, Rutter WJ & Miller AD (1990): Overexpression of the human IGF1 receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol. 10, 464-473.
28. Kramer MM & Wells CL (1996): Does physical activity reduce risk of estrogen-dependent cancer in women? Med. Sci. Sports Exerc. 28, 322-324.
29. Land CE, Hayakawa CE, Machada SJ, Yamada Y, Pike MC, Akiba S & Tokunaga M (1994): Case control study of breast cancer among Japanese atom bomb survivors. Cancer Causes Control 5, 157-165.
30. McGuire WL, Jackson JG & Figueroa JA (1992): Regulation of IGFBP expression by breast cancer cells; use of IGFBP1 as an inhibitor of IGF action. J. Natl. Cancer Inst. 84, 1336-1341.
31. Mayer-Davis EJ, Monaco JH, Hoen HM, Carmichael S, Vitolins MZ & Rewers MJ (1997): Dietary fat and insulin sensitivity in a triethnic population; the role of obesity (IRAS). Am. J. Clin. Nutr. 65, 79-87.
32. Mayer-Davis EJ, D'Agostino R, Karter AJ, Haffner SM, Rewers MJ, Saad M & Bergman RN (1998): Intensity and amount of physical activity in relation to insulin sensitivity (IRAS). JAMA 279, 669-674.
33. Modan M, Halkin H & Almog S (1985): Hyperinsulinemia; a link between hypertension, obesity and glucose intolerance. J. Clin. Invest. 75, 809-817.
34. Moorman PG, Hulka BS, Hiatt RA, Krieger N, Newman B, Vogelman JH & Orentreich N (1998): Association between HDL-C and breast cancer varies by menopausal status. Cancer Epidemiol. Biomarkers Prev. 7, 483-488.
35. Muss HB, Hunter CP, Wesley M, Correa P, Chen VW & Greenberg RS (1992): Treatment plans for black and white women with stage 2 node positive breast cancer. Cancer 70, 2460-2467.
36. Muti P, Liu J, Trevison A & Menotti A (1997): Insulin resistance as a risk factor for colon and breast cancer (abstr). Am. J. Epidemiol. 145 (Suppl. 11), S25.
37. Pathak DR & Whittemore AS (1992): Combined effects of body size, parity and menstrual events at different periods of life and breast cancer risk. Am. J. Epidemiol. 135, 153-168.
38. Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Gournier C, Lefebvre J & Demaille A (1993): Plasma IGF1 concentrations in human breast cancer. Eur. J. Cancer 29A, 492-497.
39. Pollak M (1998): Endocrine effects of IGFI on normal and transformed breast epithelial cells; potential reference to breast cancer treatment and prevention. Breast Cancer Res. Treat. 47, 209-217.
40. Pollak MN & Schally AV (1998): Mechanisms of antineoplastic action of somatostatin analogues. Proc. Soc. Exp. Biol. Med. 217, 143-152.
41. Rose DP & Connolly JM (1993): Effects of dietary n-3 fatty acids on human breast cancer growth and metastasis in nude mice. J. Natl. Cancer Inst. 85, 1743-1746.
42. Rose DP, Hatala MA, Connolly JM & Rayburn J (1993): Effects of diet containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice. Cancer Res. 53, 4686-4689.
43. Stefanick ML, Mackey S, Sheehan M, Ellsworth N, Haskell WL & Wood PD (1998): Effects of diet and exercise in men and postmenopausal women with low levels of HDL-C and high levels of LDL-C. N. Engl. J. Med. 339, 12-20.
44. Stoll BA (1998): Essential fatty acids, insulin resistance and breast cancer risk. Nutr. Cancer 31, 72-77.
45. Stoll BA & Secreto S (1992): New hormone-related markers of high risk in breast cancer. Ann. Oncol. 3, 435-438.
46. Stoll BA, Vatten LJ & Kvinnsland S (1994): Does early physical maturity influence breast cancer risk? Acta Oncol. 33, 171-176.
47. Storlien LH, Baur LA, Kriketos AD, Pan DA & Cooney GJ (1996): Dietary fats and insulin action. Diabetologia 39, 621-631.
48. Suarez A, Ramirez MC, Gill A & Faus G (1994): Dietary supplementation with long chain PUFAs of n-3 and n-6 series and with vitamin E: effect on the plasma fatty acid profile. Nutr. Hosp. 9, 170-180.
49. Tekden N, Kahraman H, Yucel J & Tanyeri F (1996): Insulin and C-peptide response to oral glucose in patients with breast cancer (abstr). Ann. Oncol. 7 (Suppl. 5), S24.
50. Thorsen T, Lahooti H, Rasmussen M & Aakvag A (1992): Oestradiol treatment increases the sensitivity of MCF7 cells for the growth-stimulatory effects of IGF1. J. Steroid Biochem. Mol. Biol. 41, 537-540.
51. Torrisi R, Pensa F, Orengo MA, Catsafadas E, Ponzani P, Boccardo F, Costa A & Decensi A (1993): The synthetic retinoid fenretinide lowers plasma IGF1 levels in breast cancer patients. Cancer Res. 53, 4769-4771.
52. Yam D, Eliraz A & Berry EM (1996): Diet and disease; the Israeli paradox; possible dangers of a high n-6 polyunsaturated fatty acid diet. Israel J. Med. Sci. 32, 1134-1143.